{"parse":{"title":"European and Developing Countries Clinical Trials Partnership","pageid":3151160,"revid":756881877,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"plainlinks metadata ambox ambox-content\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"Question book-new.svg\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article <b>may rely excessively on sources <a href=\"/wiki/Wikipedia:BLOGS\" class=\"mw-redirect\" title=\"Wikipedia:BLOGS\">too closely associated with the subject</a></b>, potentially preventing the article from being <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">verifiable</a> and <a href=\"/wiki/Wikipedia:Neutral_point_of_view\" title=\"Wikipedia:Neutral point of view\">neutral</a>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=European_and_Developing_Countries_Clinical_Trials_Partnership&amp;action=edit\">improve it</a> by replacing them with more appropriate <a href=\"/wiki/Wikipedia:Citing_sources\" title=\"Wikipedia:Citing sources\">citations</a> to <a href=\"/wiki/Wikipedia:Identifying_and_using_independent_sources\" title=\"Wikipedia:Identifying and using independent sources\">reliable, independent, third-party sources</a>.</span>  <small><i>(February 2013)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<p>The <b>European and Developing Countries Clinical Trials Partnership</b> or <b>EDCTP</b> is a partnership between the <a href=\"/wiki/European_Union\" title=\"European Union\">European Union</a> (EU), <a href=\"/wiki/Norway\" title=\"Norway\">Norway</a>, <a href=\"/wiki/Switzerland\" title=\"Switzerland\">Switzerland</a> and developing countries and other donors, as well as the <a href=\"/wiki/Pharmaceutical_industry\" title=\"Pharmaceutical industry\">pharmaceutical industry</a>, to enable <a href=\"/wiki/Clinical_trials\" class=\"mw-redirect\" title=\"Clinical trials\">clinical trials</a> and the development of new medicines and <a href=\"/wiki/Vaccine\" title=\"Vaccine\">vaccines</a> against <a href=\"/wiki/HIV\" title=\"HIV\">HIV/AIDS</a>, <a href=\"/wiki/Tuberculosis\" title=\"Tuberculosis\">tuberculosis</a>, and <a href=\"/wiki/Malaria\" title=\"Malaria\">malaria</a>.<a rel=\"nofollow\" class=\"external autonumber\" href=\"http://ec.europa.eu/research/info/conferences/edctp/edctp_en.html\">[2]</a> The need for global action against these diseases in order to promote poverty reduction has been recognised by the <a href=\"/wiki/United_Nations\" title=\"United Nations\">United Nations</a>, the <a href=\"/wiki/G8\" class=\"mw-redirect\" title=\"G8\">G8</a>, and the <a href=\"/wiki/African_Union\" title=\"African Union\">African Union</a>, and the program envisioned the provision of \u20ac600 million for the period 2003-2007 in order to translate medical research results into clinical applications relevant to the needs of developing countries.\n</p><p>The <a href=\"/wiki/European_Council\" title=\"European Council\">European Council</a> adopted the <b>Programme for Action: Accelerated action on HIV/AIDS, malaria and tuberculosis in the context of poverty reduction</b> (COM (2001)96, <a rel=\"nofollow\" class=\"external autonumber\" href=\"http://ec.europa.eu/research/info/conferences/edctp/pdf/com-2001-96_final_en.pdf\">[3]</a>) on 15 May 2001, following its launch by the <a href=\"/wiki/European_Commission\" title=\"European Commission\">European Commission</a>. The <a href=\"/wiki/European_Commission\" title=\"European Commission\">Commission</a> proposal was adopted on 16 June 2003 by the <a href=\"/wiki/European_Council\" title=\"European Council\">Council</a> and the <a href=\"/wiki/European_Parliament\" title=\"European Parliament\">European Parliament</a>.<a rel=\"nofollow\" class=\"external autonumber\" href=\"http://europa.eu/eur-lex/pri/en/oj/dat/2003/l_169/l_16920030708en00010005.pdf\">[4]</a> The Programme was to be based on three central pillars: <i>\"...the impact of existing interventions, the affordability of key pharmaceuticals and trade, and the research and development of specific <a href=\"/wiki/Global_public_good\" title=\"Global public good\">global public goods</a>.\"</i><a rel=\"nofollow\" class=\"external autonumber\" href=\"http://ec.europa.eu/research/info/conferences/edctp/pdf/background_en.pdf\">[5]</a> These aims relate specifically with the <a href=\"/wiki/European_Union\" title=\"European Union\">EU</a> stance on access to <a href=\"/wiki/Essential_medicines\" title=\"Essential medicines\">essential medicines</a>. <a rel=\"nofollow\" class=\"external autonumber\" href=\"http://ec.europa.eu/comm/trade/issues/global/medecine/index_en.htm\">[6]</a>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Projects_and_activities\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Projects and activities</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Funding\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Funding</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Member_states_and_partners_[7]\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Member states and partners [7]</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Representatives\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Representatives</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#See_also\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#External_links\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Projects_and_activities\">Projects and activities</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=European_and_Developing_Countries_Clinical_Trials_Partnership&amp;action=edit&amp;section=1\" title=\"Edit section: Projects and activities\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>EDCTP-funded activities are based on:\n</p>\n<ul><li>North/North networking and co-ordination</li></ul>\n<p>Partnerships among the <a href=\"/wiki/European_Union\" title=\"European Union\">EU</a> and associated countries, allowing focused collaboration of national and European efforts that were not previously coordinated.\n</p>\n<ul><li>North/South networking and co-ordination</li></ul>\n<p>Partnerships among <a href=\"/wiki/European_Union\" title=\"European Union\">EU</a> and developing countries that focuses specifically on developing countries' needs, who are jointly involved in setting the research priorities.\n</p>\n<ul><li>South/South networking and co-ordination</li></ul>\n<p>Efforts aimed at creating lasting long-term partnerships between African scientists and research institutions in Africa.\n</p>\n<ul><li>Supporting relevant clinical trials</li></ul>\n<p>Acceleration of the development of new or improved drugs, vaccines and microbicides against HIV/AIDS, malaria and tuberculosis, with a focus on phase II and III clinical trials in sub-Saharan Africa.\n</p>\n<ul><li>Capacity building</li></ul>\n<p>Manifested as a general strengthening of clinical research capacity in Africa, including training activities, workshops and meetings, and the upgrading of <a href=\"/wiki/Clinical_trials\" class=\"mw-redirect\" title=\"Clinical trials\">clinical trial</a> sites in Africa.\n</p>\n<h2><span class=\"mw-headline\" id=\"Funding\">Funding</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=European_and_Developing_Countries_Clinical_Trials_Partnership&amp;action=edit&amp;section=2\" title=\"Edit section: Funding\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:510px;\"><a href=\"/wiki/File:EDCTP_proposed_expenditure.png\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/1/11/EDCTP_proposed_expenditure.png\" width=\"508\" height=\"346\" class=\"thumbimage\" data-file-width=\"508\" data-file-height=\"346\" /></a>  <div class=\"thumbcaption\">Proposed EDCTP expenditure for the first 5 years of the Programme (2003-2007)<a rel=\"nofollow\" class=\"external autonumber\" href=\"http://ec.europa.eu/research/info/conferences/edctp/pdf/background_en.pdf\">[1]</a></div></div></div>\n<p>The total budget of the EDCTP is \u20ac600 million for the period 2003-2007, of which one third (\u20ac200 million) is to be provided by the <a href=\"/wiki/European_Union\" title=\"European Union\">EU</a> budget, an equivalent amounts from Member States' activities, and the remaining \u20ac200 million from industry, charities, and private organisations. The Partnership is intended to be a long-term initiative (10\u201320 years) and a separate legal entity has been created to maintain its independence and flexibility.\n</p><p>Taken together, clinical trials based in developing countries where the diseases are endemic, capacity building, and South-South networking are expected to make up over 90% of the overall budget. (figure).\n</p>\n<h2><span id=\"Member_states_and_partners_.5B7.5D\"></span><span class=\"mw-headline\" id=\"Member_states_and_partners_[7]\">Member states and partners <a rel=\"nofollow\" class=\"external autonumber\" href=\"http://ec.europa.eu/research/info/conferences/edctp/pdf/background_en.pdf\">[7]</a></span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=European_and_Developing_Countries_Clinical_Trials_Partnership&amp;action=edit&amp;section=3\" title=\"Edit section: Member states and partners [7]\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Europe\" title=\"Europe\">Europe</a></li></ul>\n<dl><dd><a href=\"/wiki/European_Union\" title=\"European Union\">EU</a> member states, plus <a href=\"/wiki/Norway\" title=\"Norway\">Norway</a> and <a href=\"/wiki/Switzerland\" title=\"Switzerland\">Switzerland</a> .</dd></dl>\n<ul><li>Developing countries</li></ul>\n<dl><dd>All sub-Saharan African countries.</dd></dl>\n<ul><li>Industry and commercial</li></ul>\n<dl><dd><a href=\"/wiki/Bayer\" title=\"Bayer\">Bayer</a></dd>\n<dd><a href=\"/wiki/GlaxoSmithKline\" title=\"GlaxoSmithKline\">GlaxoSmithKline</a></dd>\n<dd><a href=\"/w/index.php?title=Novartis_Pharma&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Novartis Pharma (page does not exist)\">Novartis Pharma</a></dd>\n<dd><a href=\"/wiki/Novo_Nordisk\" title=\"Novo Nordisk\">Novo Nordisk</a></dd>\n<dd><a href=\"/wiki/Sanofi_Pasteur\" title=\"Sanofi Pasteur\">Sanofi Pasteur</a></dd>\n<dd><a href=\"/wiki/Sanofi-Aventis\" class=\"mw-redirect\" title=\"Sanofi-Aventis\">Sanofi-Aventis</a>.</dd></dl>\n<ul><li>International initiatives</li></ul>\n<dl><dd><a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">The World Health Organization (WHO-TDR)</a> (<a rel=\"nofollow\" class=\"external free\" href=\"http://www.who.int/tdr/\">http://www.who.int/tdr/</a>)</dd>\n<dd><a href=\"/wiki/Drugs_for_Neglected_Diseases_initiative\" class=\"mw-redirect\" title=\"Drugs for Neglected Diseases initiative\">Drugs for Neglected Diseases initiative</a> (<a rel=\"nofollow\" class=\"external free\" href=\"http://www.dndi.org\">http://www.dndi.org</a>)</dd>\n<dd>International Aids Vaccine Initiative (IAVI) (<a rel=\"nofollow\" class=\"external free\" href=\"http://www.iavi.org\">http://www.iavi.org</a>)</dd>\n<dd>European Vaccine Initiative (EVI) (<a rel=\"nofollow\" class=\"external free\" href=\"http://www.euvaccine.eu\">http://www.euvaccine.eu</a>)</dd>\n<dd><a href=\"/wiki/TB_Alliance\" title=\"TB Alliance\">TB Alliance</a> (<a rel=\"nofollow\" class=\"external free\" href=\"http://www.tballiance.org\">http://www.tballiance.org</a>)</dd></dl>\n<ul><li>Private non-profit organisations</li></ul>\n<dl><dd><a href=\"/w/index.php?title=Aeras_Global_TB_Vaccine_Foundation&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Aeras Global TB Vaccine Foundation (page does not exist)\">Aeras Global TB Vaccine Foundation</a> (<a rel=\"nofollow\" class=\"external free\" href=\"http://aeras.org/home/home.php\">http://aeras.org/home/home.php</a>)</dd>\n<dd><a href=\"/wiki/Bill_%26_Melinda_Gates_Foundation\" title=\"Bill &amp; Melinda Gates Foundation\">The Bill and Melinda Gates Foundation</a> (<a rel=\"nofollow\" class=\"external free\" href=\"https://web.archive.org/web/20121012112446/http://www.gatesfoundation.org/Pages/home.aspx\">https://web.archive.org/web/20121012112446/http://www.gatesfoundation.org/Pages/home.aspx</a>)</dd>\n<dd><a href=\"/wiki/International_Partnership_for_Microbicides\" title=\"International Partnership for Microbicides\">International Partnership for Microbicides</a> (<a rel=\"nofollow\" class=\"external free\" href=\"http://www.ipm-microbicides.org\">http://www.ipm-microbicides.org</a>)</dd>\n<dd><a href=\"/wiki/Medicines_for_Malaria_Venture\" title=\"Medicines for Malaria Venture\">Medicines for Malaria Venture</a> (<a rel=\"nofollow\" class=\"external free\" href=\"http://www.mmv.org/index.php\">http://www.mmv.org/index.php</a>)</dd>\n<dd><a href=\"/wiki/Wellcome_Trust\" title=\"Wellcome Trust\">The Wellcome Trust</a> (<a rel=\"nofollow\" class=\"external free\" href=\"http://www.wellcome.ac.uk\">http://www.wellcome.ac.uk</a>)</dd></dl>\n<h2><span class=\"mw-headline\" id=\"Representatives\">Representatives</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=European_and_Developing_Countries_Clinical_Trials_Partnership&amp;action=edit&amp;section=4\" title=\"Edit section: Representatives\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>High representative - <a href=\"/wiki/Pascoal_Mocumbi\" title=\"Pascoal Mocumbi\">Pascoal Mocumbi</a>\n</p><p>Executive director - <a href=\"/w/index.php?title=Charles_Mgone&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Charles Mgone (page does not exist)\">Charles Mgone</a>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=European_and_Developing_Countries_Clinical_Trials_Partnership&amp;action=edit&amp;section=5\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/European_Organisation_for_Research_and_Treatment_of_Cancer\" title=\"European Organisation for Research and Treatment of Cancer\">European Organisation for Research and Treatment of Cancer</a> (EORTC)</li>\n<li><a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> (EMEA)</li></ul>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=European_and_Developing_Countries_Clinical_Trials_Partnership&amp;action=edit&amp;section=6\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.edctp.org\">European and Developing Countries Clinical Trials Partnership</a> (EDCTP)</li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw1303\nCached time: 20180909015936\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.084 seconds\nReal time usage: 0.103 seconds\nPreprocessor visited node count: 192/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 5480/2097152 bytes\nTemplate argument size: 321/2097152 bytes\nHighest expansion depth: 12/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 0/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.017/10.000 seconds\nLua memory usage: 817 KB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%   63.501      1 Template:Third-party_sources\n100.00%   63.501      1 -total\n 30.52%   19.383      1 Template:Ambox\n 23.99%   15.231      1 Template:DMCA\n 20.82%   13.220      1 Template:Dated_maintenance_category\n 13.85%    8.797      1 Template:FULLROOTPAGENAME\n  8.72%    5.537      1 Template:Ns_has_subpages\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:3151160-0!canonical and timestamp 20180909015936 and revision id 756881877\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","hidden":"","*":"Articles_lacking_reliable_references_from_February_2013"},{"sortkey":"","hidden":"","*":"All_articles_lacking_reliable_references"},{"sortkey":"","*":"Clinical_research"},{"sortkey":"","*":"International_medical_and_health_organizations"},{"sortkey":"","*":"National_agencies_for_drug_regulation"},{"sortkey":"","*":"Medical_and_health_organisations_based_in_the_Netherlands"}],"links":[{"ns":14,"exists":"","*":"Category:Articles lacking reliable references from February 2013"},{"ns":0,"exists":"","*":"African Union"},{"ns":0,"exists":"","*":"Bayer"},{"ns":0,"exists":"","*":"Bill & Melinda Gates Foundation"},{"ns":0,"exists":"","*":"Clinical trials"},{"ns":0,"exists":"","*":"Drugs for Neglected Diseases initiative"},{"ns":0,"exists":"","*":"Essential medicines"},{"ns":0,"exists":"","*":"Europe"},{"ns":0,"exists":"","*":"European Commission"},{"ns":0,"exists":"","*":"European Council"},{"ns":0,"exists":"","*":"European Medicines Agency"},{"ns":0,"exists":"","*":"European Organisation for Research and Treatment of Cancer"},{"ns":0,"exists":"","*":"European Parliament"},{"ns":0,"exists":"","*":"European Union"},{"ns":0,"exists":"","*":"G8"},{"ns":0,"exists":"","*":"GlaxoSmithKline"},{"ns":0,"exists":"","*":"Global public good"},{"ns":0,"exists":"","*":"HIV"},{"ns":0,"exists":"","*":"International Partnership for Microbicides"},{"ns":0,"exists":"","*":"Malaria"},{"ns":0,"exists":"","*":"Medicines for Malaria Venture"},{"ns":0,"exists":"","*":"Norway"},{"ns":0,"exists":"","*":"Novo Nordisk"},{"ns":0,"exists":"","*":"Pascoal Mocumbi"},{"ns":0,"exists":"","*":"Pharmaceutical industry"},{"ns":0,"exists":"","*":"Sanofi-Aventis"},{"ns":0,"exists":"","*":"Sanofi Pasteur"},{"ns":0,"exists":"","*":"Switzerland"},{"ns":0,"exists":"","*":"TB Alliance"},{"ns":0,"exists":"","*":"Tuberculosis"},{"ns":0,"exists":"","*":"United Nations"},{"ns":0,"exists":"","*":"Vaccine"},{"ns":0,"exists":"","*":"Wellcome Trust"},{"ns":0,"exists":"","*":"World Health Organization"},{"ns":0,"*":"Novartis Pharma"},{"ns":0,"*":"Aeras Global TB Vaccine Foundation"},{"ns":0,"*":"Charles Mgone"},{"ns":4,"exists":"","*":"Wikipedia:BLOGS"},{"ns":4,"exists":"","*":"Wikipedia:Citing sources"},{"ns":4,"exists":"","*":"Wikipedia:Identifying and using independent sources"},{"ns":4,"exists":"","*":"Wikipedia:Neutral point of view"},{"ns":4,"exists":"","*":"Wikipedia:Verifiability"},{"ns":12,"exists":"","*":"Help:Maintenance template removal"}],"templates":[{"ns":10,"exists":"","*":"Template:Third-party sources"},{"ns":10,"exists":"","*":"Template:Third-party"},{"ns":10,"exists":"","*":"Template:Ambox"},{"ns":10,"exists":"","*":"Template:DMCA"},{"ns":10,"exists":"","*":"Template:Dated maintenance category"},{"ns":10,"exists":"","*":"Template:FULLROOTPAGENAME"},{"ns":10,"exists":"","*":"Template:Ns has subpages"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Message box"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Message box/configuration"},{"ns":828,"exists":"","*":"Module:Ns has subpages"}],"images":["Question_book-new.svg","EDCTP_proposed_expenditure.png"],"externallinks":["http://ec.europa.eu/research/info/conferences/edctp/pdf/background_en.pdf","http://ec.europa.eu/research/info/conferences/edctp/edctp_en.html","http://ec.europa.eu/research/info/conferences/edctp/pdf/com-2001-96_final_en.pdf","http://europa.eu/eur-lex/pri/en/oj/dat/2003/l_169/l_16920030708en00010005.pdf","http://ec.europa.eu/comm/trade/issues/global/medecine/index_en.htm","http://www.edctp.org","http://www.who.int/tdr/","http://www.dndi.org","http://www.iavi.org","http://www.euvaccine.eu","http://www.tballiance.org","http://aeras.org/home/home.php","https://web.archive.org/web/20121012112446/http://www.gatesfoundation.org/Pages/home.aspx","http://www.ipm-microbicides.org","http://www.mmv.org/index.php","http://www.wellcome.ac.uk"],"sections":[{"toclevel":1,"level":"2","line":"Projects and activities","number":"1","index":"1","fromtitle":"European_and_Developing_Countries_Clinical_Trials_Partnership","byteoffset":1916,"anchor":"Projects_and_activities"},{"toclevel":1,"level":"2","line":"Funding","number":"2","index":"2","fromtitle":"European_and_Developing_Countries_Clinical_Trials_Partnership","byteoffset":3067,"anchor":"Funding"},{"toclevel":1,"level":"2","line":"Member states and partners [7]","number":"3","index":"3","fromtitle":"European_and_Developing_Countries_Clinical_Trials_Partnership","byteoffset":3949,"anchor":"Member_states_and_partners_[7]"},{"toclevel":1,"level":"2","line":"Representatives","number":"4","index":"4","fromtitle":"European_and_Developing_Countries_Clinical_Trials_Partnership","byteoffset":5222,"anchor":"Representatives"},{"toclevel":1,"level":"2","line":"See also","number":"5","index":"5","fromtitle":"European_and_Developing_Countries_Clinical_Trials_Partnership","byteoffset":5326,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"External links","number":"6","index":"6","fromtitle":"European_and_Developing_Countries_Clinical_Trials_Partnership","byteoffset":5454,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"European and Developing Countries Clinical Trials Partnership","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q5413467"}]}}